Literature DB >> 32356167

Characterization of a germline splice site variant MLH1 c.678-3T>A in a Lynch syndrome family.

Ciyu Yang1, Margaret Sheehan2, Ester Borras1, Karen Cadoo2, Kenneth Offit2, Liying Zhang3.   

Abstract

Germline mutations in the DNA mismatch repair (MMR) genes cause Lynch syndrome. Classification and interpretation of intronic variants, especially those outside the consensus ± 1 ~ 2 splice sites are challenging as it is uncertain whether such variants would affect splicing accuracy and efficiency. The assessment of the pathogenicity of splice site variants in MLH1 is further complicated by the various isoforms due to alternative splicing. In this report, we describe a 42-year-old female with Lynch syndrome who carries a germline variant, MLH1 c.678-3T>A, in the splice acceptor site of intron 8. Functional studies and semiquantitative analysis demonstrated that this variant causes a significant increase in the transcripts with exon 9 or exon 9 and 10 deletions, which presumably leads to premature protein truncation or abnormal protein. In addition, we also observed MSI-H and loss of MLH1 by IHC in patient's tumor tissue. This variant also segregated with Lynch Syndrome related cancers in three affected family members. Based on these evidence, the MLH1 c.678-3T>A variant is considered pathogenic.

Entities:  

Keywords:  Germline; Lynch syndrome; MLH1; Splice site variant; c.678-3T>A

Mesh:

Substances:

Year:  2020        PMID: 32356167     DOI: 10.1007/s10689-020-00180-7

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  1 in total

Review 1.  Lynch Syndrome and MSI-H Cancers: From Mechanisms to "Off-The-Shelf" Cancer Vaccines.

Authors:  Vladimir Roudko; Cansu Cimen Bozkus; Benjamin Greenbaum; Aimee Lucas; Robert Samstein; Nina Bhardwaj
Journal:  Front Immunol       Date:  2021-09-24       Impact factor: 7.561

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.